165 related articles for article (PubMed ID: 10216071)
21. Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In Mice.
Duque-Afonso J; Smith KS; Cleary ML
PLoS One; 2015; 10(11):e0143216. PubMed ID: 26588248
[TBL] [Abstract][Full Text] [Related]
22. Transformation of bone marrow B-cell progenitors by E2a-Hlf requires coexpression of Bcl-2.
Smith KS; Rhee JW; Cleary ML
Mol Cell Biol; 2002 Nov; 22(21):7678-87. PubMed ID: 12370314
[TBL] [Abstract][Full Text] [Related]
23. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells.
Altura RA; Inukai T; Ashmun RA; Zambetti GP; Roussel MF; Look AT
Blood; 1998 Aug; 92(4):1397-405. PubMed ID: 9694729
[TBL] [Abstract][Full Text] [Related]
24. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
Calvo KR; Knoepfler P; McGrath S; Kamps MP
Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
[TBL] [Abstract][Full Text] [Related]
25. E2A-HLF chimeric transcription factors in pro-B cell acute lymphoblastic leukemia.
Look AT
Curr Top Microbiol Immunol; 1997; 220():45-53. PubMed ID: 9103674
[No Abstract] [Full Text] [Related]
26. TEF, an antiapoptotic bZIP transcription factor related to the oncogenic E2A-HLF chimera, inhibits cell growth by down-regulating expression of the common beta chain of cytokine receptors.
Inukai T; Inaba T; Dang J; Kuribara R; Ozawa K; Miyajima A; Wu W; Look AT; Arinobu Y; Iwasaki H; Akashi K; Kagami K; Goi K; Sugita K; Nakazawa S
Blood; 2005 Jun; 105(11):4437-44. PubMed ID: 15665112
[TBL] [Abstract][Full Text] [Related]
27. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
O'Neil J; Billa M; Oikemus S; Kelliher M
Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
[TBL] [Abstract][Full Text] [Related]
28. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice.
Sykes DB; Kamps MP
Mol Cell Biol; 2004 Feb; 24(3):1256-69. PubMed ID: 14729970
[TBL] [Abstract][Full Text] [Related]
29. E2A-HLF usurps control of evolutionarily conserved survival pathways.
Seidel MG; Look AT
Oncogene; 2001 Sep; 20(40):5718-25. PubMed ID: 11607821
[TBL] [Abstract][Full Text] [Related]
30. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ
Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044
[TBL] [Abstract][Full Text] [Related]
31. Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein.
Matsunaga T; Inaba T; Matsui H; Okuya M; Miyajima A; Inukai T; Funabiki T; Endo M; Look AT; Kurosawa H
Blood; 2004 Apr; 103(8):3185-91. PubMed ID: 15070701
[TBL] [Abstract][Full Text] [Related]
32. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia.
Inaba T; Roberts WM; Shapiro LH; Jolly KW; Raimondi SC; Smith SD; Look AT
Science; 1992 Jul; 257(5069):531-4. PubMed ID: 1386162
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the t(17;19) translocation by gene-specific fluorescent in situ hybridization-based cytogenetics and detection of the E2A-HLF fusion transcript and protein in patients' cells.
Yeung J; Kempski H; Neat M; Bailey S; Smith O; Brady HJ
Haematologica; 2006 Mar; 91(3):422-4. PubMed ID: 16531271
[TBL] [Abstract][Full Text] [Related]
34. E2A/HLF fusion gene in an acute lymphoblastic leukemia patient with disseminated intravascular coagulation and a normal karyotype.
Dahéron L; Brizard F; Millot F; Cividin M; Lacotte L; Guilhot F; Brizard A
Hematol J; 2002; 3(3):153-6. PubMed ID: 12111652
[TBL] [Abstract][Full Text] [Related]
35. Enhanced binding of HLF/DBP heterodimers represents one mechanism of PAR protein transactivation of the factor VIII and factor IX genes.
Begbie M; Mueller C; Lillicrap D
DNA Cell Biol; 1999 Feb; 18(2):165-73. PubMed ID: 10073576
[TBL] [Abstract][Full Text] [Related]
36. Establishment of a novel cell line (TS-2) of pre-B acute lymphoblastic leukemia with a t(1;19) not involving the E2A gene.
Yoshinari M; Imaizumi M; Eguchi M; Ogasawara M; Saito T; Suzuki H; Koizumi Y; Cui Y; Sato A; Saisho T; Ichinohasama R; Matsubara Y; Kamada N; Iinuma K
Cancer Genet Cytogenet; 1998 Mar; 101(2):95-102. PubMed ID: 9494609
[TBL] [Abstract][Full Text] [Related]
37. The chimeric oncoproteins E2A-PBX1 and E2A-HLF are concentrated within spherical nuclear domains.
LeBrun DP; Matthews BP; Feldman BJ; Cleary ML
Oncogene; 1997 Oct; 15(17):2059-67. PubMed ID: 9366523
[TBL] [Abstract][Full Text] [Related]
38. E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemia.
Devaraj PE; Foroni L; Sekhar M; Butler T; Wright F; Mehta A; Samson D; Prentice HG; Hoffbrand AV; Secker-Walker LM
Leukemia; 1994 Jul; 8(7):1131-8. PubMed ID: 7518549
[TBL] [Abstract][Full Text] [Related]
39. Expression patterns of the hepatic leukemia factor gene in the nervous system of developing and adult mice.
Hitzler JK; Soares HD; Drolet DW; Inaba T; O'Connel S; MG Rosenfeld ; Morgan JI; Look AT
Brain Res; 1999 Feb; 820(1-2):1-11. PubMed ID: 10023025
[TBL] [Abstract][Full Text] [Related]
40. Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation.
Lu Q; Wright DD; Kamps MP
Mol Cell Biol; 1994 Jun; 14(6):3938-48. PubMed ID: 7910944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
